Atara Biotherapeutics Research Center in Thousand Oaks. (courtesy photo) Atara Biotherapeutics will be completing its third large-scale layoff in four years after the biotech company announced plans to shed 50% of its workforce by the end of June. Atara, a Thousand Oaks-based immunotherapy company, filed a notice with the U.S. Securities and Exchanges Commission about…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
